Khiron Life Sciences Stock Fundamentals
| KHRNF Stock | USD 0.0001 0.00 0.00% |
Khiron Life Sciences fundamentals help investors to digest information that contributes to Khiron Life's financial success or failures. It also enables traders to predict the movement of Khiron Pink Sheet. The fundamental analysis module provides a way to measure Khiron Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Khiron Life pink sheet.
Khiron |
Khiron Life Sciences Company Return On Asset Analysis
Khiron Life's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Khiron Life Return On Asset | -0.21 |
Most of Khiron Life's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Khiron Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Khiron Life Sciences has a Return On Asset of -0.2079. This is 97.62% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 48.5% higher than that of the company.
Khiron Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Khiron Life's current stock value. Our valuation model uses many indicators to compare Khiron Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Khiron Life competition to find correlations between indicators driving Khiron Life's intrinsic value. More Info.Khiron Life Sciences is rated second overall in return on equity category among its peers. It is rated third overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Khiron Life's earnings, one of the primary drivers of an investment's value.Khiron Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Khiron Life's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Khiron Life could also be used in its relative valuation, which is a method of valuing Khiron Life by comparing valuation metrics of similar companies.Khiron Life is currently under evaluation in return on asset category among its peers.
Khiron Fundamentals
| Return On Equity | -0.75 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (1.90) % | |||
| Operating Margin | (1.08) % | |||
| Current Valuation | 9.19 M | |||
| Shares Outstanding | 216.39 M | |||
| Shares Owned By Insiders | 5.00 % | |||
| Shares Owned By Institutions | 0.23 % | |||
| Price To Book | 0.45 X | |||
| Price To Sales | 0.54 X | |||
| Revenue | 12.79 M | |||
| Gross Profit | 6.37 M | |||
| EBITDA | (32.03 M) | |||
| Net Income | (33.13 M) | |||
| Cash And Equivalents | 5.82 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 705 K | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 2.83 X | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (20.4 M) | |||
| Earnings Per Share | (0.15) X | |||
| Number Of Employees | 15 | |||
| Beta | 3.05 | |||
| Market Capitalization | 17.83 M | |||
| Total Asset | 42.27 M | |||
| Z Score | 15.0 | |||
| Net Asset | 42.27 M |
About Khiron Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Khiron Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Khiron Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Khiron Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Khiron Pink Sheet
Khiron Life financial ratios help investors to determine whether Khiron Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Khiron with respect to the benefits of owning Khiron Life security.